Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China; Clinical and Translational Science Institute, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14620, United States.
Clinical and Translational Science Institute, School of Medicine and Dentistry, University of Rochester, Rochester, New York, NY 14620, United States.
Diabetes Res Clin Pract. 2019 Sep;155:107811. doi: 10.1016/j.diabres.2019.107811. Epub 2019 Aug 8.
To evaluate the effects of pre-gestational diabetes mellitus (PGDM) and gestational diabetes mellitus (GDM) on macrosomia and birth defects.
Existing birth registry data from the Perinatal Data System in Upstate New York was analysed. 650,914 women with a singleton term pregnancy (≥37 weeks) aged 18-55 years from 2004 to 2016 were included.
The prevalence of macrosomia in infants born to women with PGDM and GDM were 26.0% and 16.4%, respectively, higher than that in the controls (11.2%). Compared with the controls (0.8%), the PGDM and GDM groups had higher prevalence of any birth defect (1.8% and 1.0%). The PGDM group had the highest prevalence of cyanotic heart disease (0.6%). Moreover, the PGDM group had higher prevalence of cleft lip and palate, cleft palate alone, hypospadias and limb reduction defect compared to the GDM and control groups (p < 0.05). However, these birth defects in the GDM group were similar to those in the controls. Both the PGDM and GDM groups had significantly elevated odds of macrosomia, cyanotic heart disease and any birth defect than controls. The PGDM group had higher odds of cleft lip and palate, cleft palate alone, hypospadias and limb reduction defect.
Using the Perinatal Data System database, PGDM and GDM, especially PGDM, was associated with higher prevalence of macrosomia, cyanotic heart disease and any birth defect in singleton term pregnancy in Upstate New York. PGDM, not GDM had higher prevalence of cleft lip and palate, cleft palate alone, hypospadias and limb reduction defect.
评估孕前糖尿病(PGDM)和妊娠期糖尿病(GDM)对巨大儿和出生缺陷的影响。
分析了纽约州北部围产期数据系统的现有出生登记数据。纳入了 2004 年至 2016 年间 650914 名年龄在 18-55 岁、单胎足月(≥37 周)的妇女。
PGDM 和 GDM 组巨大儿的发生率分别为 26.0%和 16.4%,高于对照组(11.2%)。与对照组(0.8%)相比,PGDM 和 GDM 组的任何出生缺陷发生率更高(1.8%和 1.0%)。PGDM 组的青紫型心脏病发生率最高(0.6%)。此外,PGDM 组的唇裂和腭裂、单纯腭裂、尿道下裂和肢体减少缺陷的发生率均高于 GDM 组和对照组(p<0.05)。然而,GDM 组的这些出生缺陷与对照组相似。PGDM 和 GDM 组巨大儿、青紫型心脏病和任何出生缺陷的发生风险均显著高于对照组。PGDM 组唇裂和腭裂、单纯腭裂、尿道下裂和肢体减少缺陷的发生风险更高。
使用围产期数据系统数据库,PGDM 和 GDM,尤其是 PGDM,与纽约州北部单胎足月妊娠中巨大儿、青紫型心脏病和任何出生缺陷的发生率较高有关。PGDM 而非 GDM 与唇裂和腭裂、单纯腭裂、尿道下裂和肢体减少缺陷的发生率较高有关。